Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction To Survival Analysis01:18

Introduction To Survival Analysis

830
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
830
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

613
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
613
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

631
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
631
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

433
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
433
Cancer Survival Analysis01:21

Cancer Survival Analysis

774
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
774
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.1K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incorporating external risk information with the Cox model under population heterogeneity: applications to trans-ancestry polygenic hazard scores.

Journal of the Royal Statistical Society. Series A, (Statistics in Society)·2026
Same author

Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Clinical and molecular correlates of circulating tumor fraction in patients with metastatic pancreatic ductal adenocarcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma.

Nature communications·2026
Same author

Regularized Variational Estimation for Exploratory Item Factor Analysis.

Psychometrika·2026
Same author

A Note on Improving Variational Estimation for Multidimensional Item Response Theory.

Psychometrika·2026
Same journal

Orforglipron for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity or overweight: Study design and baseline characteristics of ATTAIN-OSA, a phase 3 trial.

Contemporary clinical trials communications·2026
Same journal

Implementation science and the clinical trial workforce: A national needs assessment of training and practice.

Contemporary clinical trials communications·2026
Same journal

Understanding recruitment challenges in Swiss oncology trials: Patient voices from focus groups.

Contemporary clinical trials communications·2026
Same journal

Effectiveness of couple-based maternity education on husbands' involvement in maternity continuum of care service utilization in rural communities of Central Ethiopia: Protocol of cluster randomized controlled trial.

Contemporary clinical trials communications·2026
Same journal

The design of a small Bayesian hybrid-controlled trial utilizing time-to-event data from six published sources that used best alternative care to treat liver-predominant metastasis from primary ocular melanoma.

Contemporary clinical trials communications·2026
Same journal

A family navigator model for foster parents to promote youth mental health wellness: Study development and protocol.

Contemporary clinical trials communications·2026
See all related articles

Related Experiment Video

Updated: Feb 10, 2026

Quantitative Analysis of Random Migration of Cells Using Time-lapse Video Microscopy
07:27

Quantitative Analysis of Random Migration of Cells Using Time-lapse Video Microscopy

Published on: May 13, 2012

17.3K

Survival analysis following dynamic randomization.

Xiaolong Luo1, Mingyu Li1, Gongjun Xu2

  • 1Biometrics and Data Operations, Celgene Corporation, 300 Connell Drive, 3-7059 Berkeley Heights, NJ 07922, USA.

Contemporary Clinical Trials Communications
|May 9, 2018
PubMed
Summary
This summary is machine-generated.

This study introduces a new statistical method for analyzing clinical trial survival data with dynamic randomization. The proposed approach accurately estimates treatment effects and tests hypotheses in complex trial designs.

More Related Videos

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis
09:02

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis

Published on: February 20, 2021

3.5K
Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

6.9K

Related Experiment Videos

Last Updated: Feb 10, 2026

Quantitative Analysis of Random Migration of Cells Using Time-lapse Video Microscopy
07:27

Quantitative Analysis of Random Migration of Cells Using Time-lapse Video Microscopy

Published on: May 13, 2012

17.3K
Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis
09:02

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis

Published on: February 20, 2021

3.5K
Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

6.9K

Area of Science:

  • Biostatistics
  • Clinical Trials Methodology
  • Survival Analysis

Background:

  • Dynamic randomization is increasingly used in clinical trials.
  • Standard survival analysis methods may not adequately account for dynamic randomization processes.
  • Accurate analysis is crucial for reliable treatment effect estimation.

Purpose of the Study:

  • To propose a novel statistical method for analyzing survival data from clinical trials with dynamic subject enrollment.
  • To directly incorporate the dynamic randomization process into the analysis framework.
  • To provide a robust method for estimating treatment effects and performing hypothesis testing.

Main Methods:

  • Utilized a marked point process (MPP) to model the dynamic randomization.
  • Employed the corresponding martingale process to derive estimation equations.
  • Developed a framework for treatment effect size estimation and hypothesis testing.

Main Results:

  • Simulation analyses demonstrated the performance of the proposed MPP method.
  • Compared the proposed method against the conventional log rank test and re-randomized testing.
  • Evaluated the accuracy and reliability of the new method under dynamic randomization.

Conclusions:

  • The proposed marked point process method offers a statistically sound approach for survival data analysis in dynamically randomized trials.
  • This method provides a more accurate estimation of treatment effects compared to conventional approaches.
  • The findings support the adoption of this advanced statistical technique in clinical trial design and analysis.